Conklin Jessica R, Togami John C, Burnett Allison, Dodd Melanie A, Ray Gretchen M
Jessica R. Conklin, Pharm.D., PhC, is Visiting Assistant Professor, Department of Pharmacy Practice & Administrative Sciences, University of New Mexico (UNM) College of Pharmacy, Albuquerque; at the time of the study, she was Postgraduate Year 2 (PGY2) Ambulatory Care Pharmacy Resident, UNM College of Pharmacy. John C. Togami, Pharm.D., is PGY2 Ambulatory Care Pharmacy Resident, UNM College of Pharmacy; at the time of the study, he was Postgraduate Year 1 Pharmacy Resident, UNM Hospital, Albuquerque. Allison Burnett, Pharm.D., PhC, is Clinical Pharmacist, UNM Hospital. Melanie A. Dodd, Pharm.D., PhC, BCPS, is Associate Professor; and Gretchen M. Ray, Pharm.D., PhC, BCPS, is Assistant Professor, Department of Pharmacy Practice & Administrative Sciences, UNM College of Pharmacy.
Am J Health Syst Pharm. 2014 May 15;71(10):802-10. doi: 10.2146/ajhp130589.
A quality-improvement program at University of New Mexico Hospital (UNMH) encompassing admission, discharge, and postdischarge medication reconciliation activities is described, with a report on initial assessments of the program's impact on rates of medication-related problems (MRPs).
Pharmacists conducted a five-month evaluation of the UNMH Care Transitions Service (CTS), which serves inpatients admitted to the hospital's family medicine service, providing medication reconciliation and targeted MRP interventions. Selected patients who received CTS services from November 2012 through March 2013 (n = 191) were included in the analysis. The study endpoints were the rates and types of MRPs identified, the most commonly implicated medication classes, and predictors of MRPs. Postdischarge MRP rates during a two-month trial of CTS services at a UNMH outpatient clinic were also evaluated.
During the five-month evaluation of inpatient CTS services, a total of 1140 MRPs were identified (an average of 6 per patient), about 70% of which were resolved independently of provider review using pharmacy-driven protocols. During the two-month pilot test of CTS outpatient services (n = 16), a total of 28 MRPs were identified; in over 80% of cases, there was a decline in the number of MRPs from the admission to the postdischarge medication reconciliation.
MRPs were identified through the continuum of care. The majority of MRPs identified in both the inpatient and outpatient settings involved patient variables and patient nonadherence. Seventy percent of inpatient MRPs were resolved independently by the CTS team under pharmacy-driven protocols.
描述了新墨西哥大学医院(UNMH)开展的一项质量改进项目,该项目涵盖入院、出院及出院后用药核对活动,并报告了该项目对用药相关问题(MRP)发生率影响的初步评估情况。
药剂师对UNMH护理转接服务(CTS)进行了为期五个月的评估,该服务面向入住医院家庭医学科的住院患者,提供用药核对及针对性的MRP干预措施。分析纳入了2012年11月至2013年3月期间接受CTS服务的选定患者(n = 191)。研究终点为所识别的MRP的发生率和类型、最常涉及的药物类别以及MRP的预测因素。还评估了在UNMH门诊诊所进行的为期两个月的CTS服务试验期间的出院后MRP发生率。
在对住院CTS服务的五个月评估期间,共识别出1140个MRP(平均每位患者6个),其中约70%通过药房驱动的方案独立解决,无需医生审核。在CTS门诊服务的两个月试点测试中(n = 16),共识别出28个MRP;在超过80%的病例中,从入院到出院后用药核对期间MRP的数量有所下降。
通过连续护理过程识别出了MRP。在住院和门诊环境中识别出的大多数MRP涉及患者变量和患者不依从情况。70%的住院MRP由CTS团队根据药房驱动的方案独立解决。